News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,905 Results
Type
Article (87486)
Company Profile (807)
Press Release (773590)
Multimedia
Podcasts (176)
Webinars (28)
Section
Business (233075)
Career Advice (4140)
Deals (39802)
Drug Delivery (138)
Drug Development (91268)
Employer Resources (203)
FDA (18290)
Job Trends (17403)
News (397443)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1687)
Antibody-drug conjugate (ADC) (257)
Approvals (18326)
Artificial intelligence (506)
Autoimmune disease (93)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (137)
Brain cancer (53)
Breast cancer (514)
Cancer (4080)
Cardiovascular disease (354)
Career advice (3560)
Career pathing (38)
CAR-T (251)
CDC (57)
Cell therapy (698)
Cervical cancer (33)
Clinical research (75696)
Collaboration (1425)
Company closure (4)
Compensation (943)
Complete response letters (60)
COVID-19 (2961)
CRISPR (82)
C-suite (610)
Cystic fibrosis (140)
Data (4737)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7101)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (241)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98985)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133215)
Executive appointments (996)
FDA (20830)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1284)
Gene editing (175)
Generative AI (52)
Gene therapy (558)
GLP-1 (1027)
Government (5389)
Grass and pollen (7)
Guidances (363)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (55)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (195)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (269)
Machine learning (32)
Management (66)
Manufacturing (654)
MASH (145)
Medical device (14897)
Medtech (14922)
Mergers & acquisitions (22769)
Metabolic disorders (1173)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2745)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (564)
Opinion (315)
Ovarian cancer (138)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (426)
Patient recruitment (329)
Peanut (57)
People (66317)
Pharmaceutical (145)
Pharmacy benefit managers (28)
Phase I (23349)
Phase II (32848)
Phase III (24768)
Pipeline (2788)
Policy (297)
Postmarket research (3554)
Preclinical (10535)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (691)
Real estate (7422)
Recruiting (79)
Regulatory (28086)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (139)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (111)
Vaccines (1057)
Venture capital (67)
Weight loss (400)
Women's health (60)
Worklife (21)
Date
Today (160)
Last 7 days (756)
Last 30 days (2910)
Last 365 days (33602)
2025 (27441)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1281)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51031)
Australia (8971)
California (9663)
Canada (2901)
China (927)
Colorado (408)
Connecticut (431)
Delaware (277)
Europe (117254)
Florida (1424)
Georgia (319)
Hawaii (3)
Idaho (67)
Illinois (820)
India (54)
Indiana (479)
Iowa (20)
Japan (330)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1294)
Massachusetts (7243)
Michigan (317)
Minnesota (573)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2685)
New Mexico (32)
New York (2622)
North Carolina (1426)
North Dakota (10)
Northern California (4411)
Ohio (304)
Oklahoma (22)
Oregon (51)
Pennsylvania (2005)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3686)
Tennessee (152)
Texas (1523)
United States (35638)
Utah (287)
Virginia (251)
Washington D.C. (84)
Washington State (830)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,905 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
J&J, Lilly Crest AI Wave With Nvidia Partnerships
Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to create the industry’s ‘most powerful supercomputer’ and J&J building a virtual operating room.
October 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ionis reports third quarter 2025 financial results and highlights progress on key programs
October 29, 2025
·
18 min read
Press Releases
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
October 29, 2025
·
19 min read
Press Releases
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy
October 29, 2025
·
3 min read
Press Releases
Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025
October 29, 2025
·
1 min read
Press Releases
Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
October 29, 2025
·
1 min read
Press Releases
Kamada to Present at the Stifel 2025 Healthcare Conference
October 29, 2025
·
2 min read
Press Releases
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund
October 29, 2025
·
5 min read
Press Releases
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
October 29, 2025
·
2 min read
Press Releases
Amarin Reports Third Quarter 2025 Financial Results
October 29, 2025
·
17 min read
1 of 86,191
Next
